Literature DB >> 28401430

Bilateral Effects of Excipients on Protein Stability: Preferential Interaction Type of Excipient and Surface Aromatic Hydrophobicity of Protein.

Lili Wen1, Xianxian Zheng1, Xinyue Wang1, Hairong Lan1, Zongning Yin2.   

Abstract

PURPOSE: Understanding the mechanism of protein-excipient interaction and illuminating the influencing factors on protein stability are key steps in the rational design of protein formulations. The objective of this study was to assess effects of preferential interaction type of excipient and surface aromatic hydrophobicity of protein on protein solution stability.
METHODS: The preferential interaction between excipient and aromatic hydrophobic area of protein was investigated by solubility and fluorescence studies of amino acid derivatives in excipient solutions. We examined conformational, colloidal and mechanical stabilities of model proteins with different surface aromatic hydrophobicities, including bovine serum albumin (BSA) and ovalbumin (OVA), and then stability data were visualized by three-index empirical phase diagram.
RESULTS: The result showed that preferentially excluded excipients (trehalose, sucrose and sorbitol) protected protein conformation against damage, but they could accelerate mechanical stress-induced aggregation. Preferentially bound excipients (propanediol and arginine) suppressed BSA aggregation, but arginine failed to inhibit OVA aggregation, which might be attributed to the disparate conformational perturbing effects of arginine on aromatic hydrophobic regions of BSA and OVA.
CONCLUSIONS: These findings provided strong evidence that excipient possessed bilateral effects, and its application should be determined on different preferential interaction behaviors of excipients with protein, especially with the aromatic hydrophobic region.

Entities:  

Keywords:  Conformational change; excipient; preferential interaction; protein stability; surface aromatic hydrophobicity

Mesh:

Substances:

Year:  2017        PMID: 28401430     DOI: 10.1007/s11095-017-2152-0

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  39 in total

1.  Shaken, not stirred: mechanical stress testing of an IgG1 antibody.

Authors:  Sylvia Kiese; Astrid Papppenberger; Wolfgang Friess; Hanns-Christian Mahler
Journal:  J Pharm Sci       Date:  2008-10       Impact factor: 3.534

2.  Label-free flow cytometry analysis of subvisible aggregates in liquid IgG1 antibody formulations.

Authors:  Hirotaka Nishi; Roman Mathäs; Robert Fürst; Gerhard Winter
Journal:  J Pharm Sci       Date:  2013-11-11       Impact factor: 3.534

3.  Controlling protein stability: Mechanisms revealed using formulations of arginine, glycine and guanidinium HCl with three globular proteins.

Authors:  Lauren Platts; Robert J Falconer
Journal:  Int J Pharm       Date:  2015-03-27       Impact factor: 5.875

Review 4.  Pharmacokinetic studies of protein drugs: past, present and future.

Authors:  Eric Ezan
Journal:  Adv Drug Deliv Rev       Date:  2013-03-27       Impact factor: 15.470

5.  The role of electrostatics in protein-protein interactions of a monoclonal antibody.

Authors:  D Roberts; R Keeling; M Tracka; C F van der Walle; S Uddin; J Warwicker; R Curtis
Journal:  Mol Pharm       Date:  2014-06-18       Impact factor: 4.939

6.  Stabilization of protein structure by sugars.

Authors:  T Arakawa; S N Timasheff
Journal:  Biochemistry       Date:  1982-12-07       Impact factor: 3.162

7.  Quantitative evaluation of colloidal stability of antibody solutions using PEG-induced liquid-liquid phase separation.

Authors:  Ying Wang; Ramil F Latypov; Aleksey Lomakin; Julie A Meyer; Bruce A Kerwin; Suresh Vunnum; George B Benedek
Journal:  Mol Pharm       Date:  2014-04-15       Impact factor: 4.939

8.  Inhibition of agitation-induced aggregation of an IgG-antibody by hydroxypropyl-beta-cyclodextrin.

Authors:  Tim Serno; John F Carpenter; Theodore W Randolph; Gerhard Winter
Journal:  J Pharm Sci       Date:  2010-03       Impact factor: 3.534

9.  Excipients differentially influence the conformational stability and pretransition dynamics of two IgG1 monoclonal antibodies.

Authors:  Santosh V Thakkar; Sangeeta B Joshi; Matthew E Jones; Hasige A Sathish; Steven M Bishop; David B Volkin; C Russell Middaugh
Journal:  J Pharm Sci       Date:  2012-05-11       Impact factor: 3.534

10.  Highly aggregated antibody therapeutics can enhance the in vitro innate and late-stage T-cell immune responses.

Authors:  Marisa K Joubert; Martha Hokom; Catherine Eakin; Lei Zhou; Meghana Deshpande; Matthew P Baker; Theresa J Goletz; Bruce A Kerwin; Naren Chirmule; Linda O Narhi; Vibha Jawa
Journal:  J Biol Chem       Date:  2012-05-14       Impact factor: 5.157

View more
  1 in total

1.  Effects of Monovalent Salt on Protein-Protein Interactions of Dilute and Concentrated Monoclonal Antibody Formulations.

Authors:  Amy Y Xu; Nicholas J Clark; Joseph Pollastrini; Maribel Espinoza; Hyo-Jin Kim; Sekhar Kanapuram; Bruce Kerwin; Michael J Treuheit; Susan Krueger; Arnold McAuley; Joseph E Curtis
Journal:  Antibodies (Basel)       Date:  2022-03-31
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.